like CICS, IMS, DB/2 and MQ and send security related data to external products like QRadar and ArcSight. As software...-system knowledge of one or more sub-systems like: DB2, CICS, IMS and/or MQ Experienced with z/OS (“Principles Of Operation...
, we also support multiple subsystems like CICS, IMS, DB/2 and MQ and send security related data to external products like QRadar... experience on the IBM z Server platform Sub-system knowledge of one or more sub-systems like: DB2, CICS, IMS and/or MQ...
. Knowledge of the z/VM platform is an additional advantage. As we support multiple sub-systems like CICS, DB2, IMS, MQ... to be a plus Sub-system knowledge of one or more sub-systems like: DB2, CICS, IMS and/or MQ Some experience with the zSecure software...
The trends on Gift Nifty also indicate a positive start for the Indian benchmark index. The Gift Nifty was trading around 22,890 level, a premium of nearly 115 points from the Nifty futures’ previous close. Continue Reading »
Indian stock market: Gift Nifty was trading around the 22,900 level, a premium of nearly 125 points from the Nifty futures’ previous close, indicating a positive start for the Indian stock market indices. Continue Reading »
Crude prices came under pressure after US data pointed to persistent labour market strength which further dimmed prospects of an early decline in US interest rates. Continue Reading »
Freshworks now expects annual revenue between $695 million and $705 million, compared with its previous forecast of $703.5 million to $711.5 million. Continue Reading »
While gold is traditionally considered a hedge against inflation, high interest rates kept by the US Fed to tame the rising prices can increase the opportunity cost of holding the non-yielding bullion. Continue Reading »
Manpansand Beverages' top officials have been asked to pay penalties totaling ₹74 lakh by SEBI for violations including misstating and manipulating financial statements. Continue Reading »
Stock Market Today- Cipla, Aurobindo, Torrent are 3 preferred picks of HSBC Research on healthy Q4 expectations. HSBC expects 38.4% y-o-y rise in net profit of pharma companies in their coverage during Q4 helped by rising US sales compensating for slower growth in India Continue Reading »